New patent for Corcept Therap drug KORLYM

Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are thirteen patents protecting this drug and one Paragraph…

The post New patent for Corcept Therap drug KORLYM appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog